Anebulo shareholders approve authorized share increase to 75M, stock plan expansion, and removal of 10.1M-share lock-up

Anebulo Pharmaceuticals, Inc.

Authorized common stock increased from 50M to 75M shares; stock incentive plan pool raised by 2.5M to 6.15M shares.
Voting and transfer restrictions on 10,101,010 shares held by 22NW Fund, LP removed per shareholder approval.
Class I directors Joseph F. Lawler, Richard Anthony Cunningham, Aron R. English re-elected.
Ratification of EisnerAmper LLP as independent auditor for fiscal 2025 approved.
All proposals passed with strong majorities; record date had 41,084,731 shares outstanding.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.